Abstract
There are different regimens of dual antiplatelet therapy (DAPT) after placement of drug-eluting stents in patients with acute coronary syndrome (ACS). We aim to evaluate the clinical outcomes after switching from clopidogrel (CLO) to ticagrelor (TIC) or vice versa at discharge. The study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
